BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24908623)

  • 21. Acute generalized exanthematous pustulosis induced by hydroxychloroquine.
    Hsieh CH; Yao CA; Lo Y
    Kaohsiung J Med Sci; 2021 Dec; 37(12):1122-1123. PubMed ID: 34390130
    [No Abstract]   [Full Text] [Related]  

  • 22. Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
    Schwartz RA; Janniger CK
    Dermatol Ther; 2020 May; 33(3):e13380. PubMed ID: 32253799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital.
    Nili A; Zarei E; Ghamari A; Farid AS; Tavakolpour S; Daneshpazhooh M; Mahmoudi H
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107093. PubMed ID: 33091817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
    Lee HY; Chou D; Pang SM; Thirumoorthy T
    Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-pigmenting fixed drug eruption with mixed features of acute generalized exanthematous pustulosis induced by pseudoephedrine: a case report.
    Fukuda R; Ouchi T; Hirai I; Funakoshi T; Honda A; Tanese K; Tanikawa A; Amagai M; Takahashi H
    Contact Dermatitis; 2017 Aug; 77(2):123-126. PubMed ID: 28703347
    [No Abstract]   [Full Text] [Related]  

  • 26. Case of generalized pustular psoriasis that might have progressed from terbinafine-induced acute generalized exanthematous pustulosis.
    Yasuno S; Yamaguchi M; Tanaka A; Umehara K; Okita T; Asano N; Kashiwagi K; Shimomura Y
    J Dermatol; 2018 Dec; 45(12):e328-e329. PubMed ID: 29766566
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
    Enos T; Jeong HS; Vandergriff T; Jacobe HT; Chong BF
    Dermatol Ther; 2020 Nov; 33(6):e13834. PubMed ID: 32542893
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute generalized exanthematous pustulosis associated with terbinafine: a case report.
    Turan H; Acer E; Erdem H; Uslu E; Aliagaoglu C
    Cutan Ocul Toxicol; 2013 Oct; 32(4):325-6. PubMed ID: 23432048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiating generalized pustular psoriasis from acute generalized exanthematous pustulosis.
    Yamanaka-Takaichi M; Watanabe M; Comfere NI; Sokumbi O; Akpala CO; Todd A; Branch EL; Mangold AR; Hiroyasu S; Tsuruta D; Alavi A
    J Am Acad Dermatol; 2024 Jun; 90(6):1289-1291. PubMed ID: 38483432
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hydroxychloroquine-puvatherapy photoinduced acute generalized exanthematous pustulosis].
    Bonnetblanc JM; Combeau A; Dang PM
    Ann Dermatol Venereol; 1995; 122(9):604-5. PubMed ID: 8745685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
    Robustelli Test E; Vezzoli P; Carugno A; Raponi F; Gianatti A; Rongioletti F; Sena P
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e457-e459. PubMed ID: 32386448
    [No Abstract]   [Full Text] [Related]  

  • 32. Generalized pustular eruptions due to terbinafine.
    Ozturk G; Turk BG; Karaca N; Karaarslan IK; Ertekin B; Ertam I; Kazandi A; Kandiloglu G
    Cutan Ocul Toxicol; 2012 Mar; 31(1):81-4. PubMed ID: 21888496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
    Atak MF; Farabi B; Akbayrak A; Kalelioğlu MB; Rao BK
    J Cosmet Dermatol; 2021 Aug; 20(8):2387-2389. PubMed ID: 34139069
    [No Abstract]   [Full Text] [Related]  

  • 34. Widespread pustular eruption following probiotic use.
    Price KN; Hendricks AJ; Goodrich ME; Krase JM; Shi VY
    Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Generalized Exanthematous Pustulosis Induced by Amoxicillin/Clavulanic Acid: Report of a Case Presenting With Generalized Lymphadenopathy.
    Syrigou E; Grapsa D; Charpidou A; Syrigos K
    J Cutan Med Surg; 2015; 19(6):592-4. PubMed ID: 25997755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute generalized exanthematous pustulosis (AGEP): A review and update.
    Szatkowski J; Schwartz RA
    J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pustular drug eruption].
    Schrumpf E; Rizvi SMH
    Tidsskr Nor Laegeforen; 2018 Nov; 138(18):. PubMed ID: 30421738
    [No Abstract]   [Full Text] [Related]  

  • 38. Late-onset AGEP-like skin pustular eruption following COVID-19: A possible association.
    Ayatollahi A; Robati RM; Kamyab K; Firooz A
    Dermatol Ther; 2020 Nov; 33(6):e14275. PubMed ID: 32885892
    [No Abstract]   [Full Text] [Related]  

  • 39. Young Woman With Diffuse Pustular Rash.
    Thurman RJ; Hadley ED
    Ann Emerg Med; 2016 May; 67(5):576-87. PubMed ID: 27106365
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute generalized exanthematous pustulosis induced by gliclazide: a case report.
    Contreras-Steyls M; Vílchez-Márquez F; Mota A; Moyano B; Herrera-Ceballos E
    Int J Dermatol; 2013 Dec; 52(12):1591-3. PubMed ID: 24261739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.